🚀 BiFinance IPO Series | 天辰生物-B HK STOCK IPO
👉
As a biotechnology company focused on innovative drug development, 天辰生物-B is committed to creating globally best-in-class and first-in-class therapies for cancer and other serious diseases.
🧬 Biotech × HK Stock IPO
🌍 Bridging Traditional Finance and Web3
📈 IPO Price: 96.06 HKD
⏰ Subscription Starts: 2026/5/28 9:00
Innovation in biotechnology is accelerating toward global capital markets, reshaping the future of healthcare and finance.
#
BiFinance# #
IPO# #
HKStocks# #
Biotech# #
Web3#